Fresenius Medical Care AG & Co. KGaA FME.MI Stock
Fresenius Medical Care AG & Co. KGaA Price Chart
Fresenius Medical Care AG & Co. KGaA FME.MI Financial and Trading Overview
Fresenius Medical Care AG & Co. KGaA stock price | 36.64 EUR |
Previous Close | 37.77 EUR |
Open | 37.55 EUR |
Bid | 36.95 EUR x 0 |
Ask | 0 EUR x 0 |
Day's Range | 36.64 - 37.55 EUR |
52 Week Range | 26.54 - 50.02 EUR |
Volume | 95 EUR |
Avg. Volume | 110 EUR |
Market Cap | 11.29B EUR |
Beta (5Y Monthly) | 0.883558 |
PE Ratio (TTM) | 15.930435 |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | 1.12 (2.97%) |
Ex-Dividend Date | May 17, 2023 |
1y Target Est | N/A |
FME.MI Valuation Measures
Enterprise Value | 23.96B EUR |
Trailing P/E | 15.930435 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.5821973 |
Price/Book (mrq) | 0.7684886 |
Enterprise Value/Revenue | 1.235 |
Enterprise Value/EBITDA | 9.631 |
Trading Information
Fresenius Medical Care AG & Co. KGaA Stock Price History
Beta (5Y Monthly) | 0.883558 |
52-Week Change | -13.0084% |
S&P500 52-Week Change | 20.43% |
52 Week High | 50.02 EUR |
52 Week Low | 26.54 EUR |
50-Day Moving Average | 41.77 EUR |
200-Day Moving Average | 34.62 EUR |
FME.MI Share Statistics
Avg. Volume (3 month) | 110 EUR |
Avg. Daily Volume (10-Days) | 7 EUR |
Shares Outstanding | 293.41M |
Float | 198.92M |
Short Ratio | N/A |
% Held by Insiders | 32.16% |
% Held by Institutions | 39.71% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.12 |
Trailing Annual Dividend Yield | 2.96% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.587 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.47% |
Operating Margin (ttm) | 8.12% |
Gross Margin | 27.37% |
EBITDA Margin | 12.82% |
Management Effectiveness
Return on Assets (ttm) | 2.80% |
Return on Equity (ttm) | 6.07% |
Income Statement
Revenue (ttm) | 19.4B EUR |
Revenue Per Share (ttm) | 66.15 EUR |
Quarterly Revenue Growth (yoy) | 7.50% |
Gross Profit (ttm) | 5.31B EUR |
EBITDA | 2.49B EUR |
Net Income Avi to Common (ttm) | 673.4M EUR |
Diluted EPS (ttm) | 2.3 |
Quarterly Earnings Growth (yoy) | -39.30% |
Balance Sheet
Total Cash (mrq) | 1.46B EUR |
Total Cash Per Share (mrq) | 4.98 EUR |
Total Debt (mrq) | 13.21B EUR |
Total Debt/Equity (mrq) | 85.52 EUR |
Current Ratio (mrq) | 1.268 |
Book Value Per Share (mrq) | 47.678 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.17B EUR |
Levered Free Cash Flow (ttm) | 1.05B EUR |
Profile of Fresenius Medical Care AG & Co. KGaA
Country | Italy |
State | N/A |
City | Bad Homburg |
Address | Else-KrOener-Strasse 1 |
ZIP | 61352 |
Phone | 49 6172 609 0 |
Website | https://www.freseniusmedicalcare.com |
Industry | Medical Care Facilities |
Sector(s) | Healthcare |
Full Time Employees | 128044 |
Fresenius Medical Care AG & Co. KGaA provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Q&A For Fresenius Medical Care AG & Co. KGaA Stock
What is a current FME.MI stock price?
Fresenius Medical Care AG & Co. KGaA FME.MI stock price today per share is 36.64 EUR.
How to purchase Fresenius Medical Care AG & Co. KGaA stock?
You can buy FME.MI shares on the Milan exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fresenius Medical Care AG & Co. KGaA?
The stock symbol or ticker of Fresenius Medical Care AG & Co. KGaA is FME.MI.
Which industry does the Fresenius Medical Care AG & Co. KGaA company belong to?
The Fresenius Medical Care AG & Co. KGaA industry is Medical Care Facilities.
How many shares does Fresenius Medical Care AG & Co. KGaA have in circulation?
The max supply of Fresenius Medical Care AG & Co. KGaA shares is 296.87M.
What is Fresenius Medical Care AG & Co. KGaA Price to Earnings Ratio (PE Ratio)?
Fresenius Medical Care AG & Co. KGaA PE Ratio is 0.00000000 now.
What was Fresenius Medical Care AG & Co. KGaA earnings per share over the trailing 12 months (TTM)?
Fresenius Medical Care AG & Co. KGaA EPS is 0 EUR over the trailing 12 months.
Which sector does the Fresenius Medical Care AG & Co. KGaA company belong to?
The Fresenius Medical Care AG & Co. KGaA sector is Healthcare.